Delayed graft function of more than six days strongly decreases long- term survival of transplanted kidneys

Kidney International

Volumn 54, Issue 3, 1998, Pages 972-978

  Giral Classe, M ^a   Hourmant, M ^a   Cantarovich, D ^a   Dantal, J ^a   Blancho, G ^a   Daguin, P ^a   Ancelet, D ^a   Soulillou, J P ^a  

^a HÔTEL DIEU   (France)

Author keywords

Dialysis; Graft survival; Mortality prediction; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CADAVER; CADAVER DONOR; CREATININE CLEARANCE; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SURVIVAL TIME;

EID: 0031658760     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00071.x     Document Type: Article

References (24)

1. C.G.K. Troppmann E. Benedetti S. Almond R.W.G. Gruessner J.S. Najarian A.J. Matas Delayed graft function, acute rejection, and outcome after cadaver reanal transplantation Transplantation 59 1995 962 968
2. H.I.G.R. Feldman A. Berlin D.A. Roth R. Sibolobovsky S. Kushner K.L. Brayman J. Eilen Burns S.M. Kobrin A.L. Friedman A. Grossman Delayed function reduces renal allograft survival independent of acute rejection Nephrol Dial Transplant 11 1996 1306 1313
3. W. Land K. Messmer The impact of ischemia/reperfusion injury on specific and non-specific early and late chronic events after organ transplantation Transplant Rev 10 1996 108 127
4. K.J. Kelly W.W. Williams R.B. Colvin J.V. Bonventre Antibodies to InterCellular adhesion molecule I protects the kidney against ischemic injury PNAS 91 1994 812 816
5. M. Hourmant J. Bedrossian D. Durand Y. Lebranchu E. Renoult P. Caudrelier R. Buffet J.P. Soulillou A randomized multicenter trial comparing LFA1 monoclonal antibody with rabbit anti-thymocyte globulin as induction treatment in first kidney transplantation Transplantation 62 1996 1565 1570
6. Troppman G.K. C K.J. Gillingham W.G. Gruessnerr D.L. Dunn W.D. Payne J.S. Nayarian A.J. Matas Delayed graft function in the absence of rejection has no long-term impact Transplantation 61 1996 1331 1337
7. Ojo W.R. AO P.J. Held F.K. Port R.L. Schmouder Delayed graft function: Risk factors and implications for renal allograft survival Transplantation 633 1997 968 974
8. J.D.P.R. Pirsch S. Gange A.M. D’Alessandro S.J. Knechtle H.W. Sollinger M. Kalayoglu O.F. Belzer Determinant of graft survival after renal transplantation Transplantation 61 1996 1581 1586
9. M. Robertshaw N.K. Lai R. Swaminathan Restriction of creatinine clearance from plasma creatinine: Comparison of five formulae Br J Clin Pharmac 28 1989 275 280
10. D.W. Cockcroft M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
11. J. Dantal E. Ninin M. Hourmant F. Boeffard D. Cantarovich M. Giral J. Wijdenes J.P. Soulillou B. Le Mauff Anti-CD4 MoAb therapy in kidney transplantation. A pilot study in early prophylaxis of rejection Transplantation 62 1996 1502 1506
12. J.P. Soulillou D. Cantarovich B. Le Mauff M. Giral M. Hourmant M. Hirn Y. Jacques Randomized trial of an anti-interleukin 2 receptor monoclonal antibody (33B3.1) versus rabbit antithymocyte globulin (ATG) in prophylaxis of early rejection in human renal transplantation N Engl J Med 322 1990 1175 1182
13. M. Giral M.C. Cuturi J.M. Nguyen R. Josien J. Dantal R. Floc'h R. Buelow P. Pouletty J.P. Soulillou Decreased cytotoxic activity of natural killer cells in kidney allograft recipients treated with human HLA-derived peptide Transplantation 63 1997 1004 1011
14. J.T. Rosenthal A. Wilkinson R.B. Ettenger The high cost of delayed graft function in cadaveric renal transplantation Transplantation 51 1991 1115 1117
15. C.Y. Hirata J.M. Cecka P. Terasaki Patients death after renal transplantation–An analysis of its role in graft outcome Transplantation 61 1996 1479 1483
16. P.A.M. Halloran V. Farewell D. Ludwin E.K. Smith S.Y. Tsai R.A. Bear E.H. Cole S.S. Fenton D.C. Cattran Early function as the principal correlate of graft survival Transplantation 46 1988 223 228
17. P.A.M. Halloran V. Farewell Factors influencing early renal fuction in cadaver kidney transplants Transplantation 45 1988 122 127
18. M.L.W.T. Nicholson T. Horsburgh C.M. Edwards P.S. Veitch P.R.F. Bell The relative influence of delayed graft function and acute rejection on renal transplant survival Transplant Int 9 1996 415 419
19. J.S. Najarian K.J. Gillingham D.E.R. Sutherland N.L. Reinsmoen W.D. Payne A.J. Matas The impact of the quality of initial graft function on cadaver kidney transplants Transplantation 57 1994 812 816
20. A. Humar E.M. Johnson W.D. Payne L. Wrenshall D.E. Sutherland J.S. Najarian K.J. Gillingham A.J. Matas Effect of initial graft function on renal allograft rejection and survival Clin Transplant 11 1997 623 627
21. B.M. Brenner Nephron underdosing: A programmed cause of chronic allograft failure Am J Kidney Dis 21 1993 66 72
22. F. Sanfilippo W.K. Vaughn E.K. Spees B.A. Lucas The detrimental effects of delayed graft function in cadavre donor renal transplantation Transplantation 38 1984 643 648
23. A.M. De Mattos T.F. Andoh W.M. Bennett Cyclosporine nephropathy: Clinical histological and functional aspects Transplant Rev 10 1996 225 235
24. G. Opelz Collaborative Transplant Study Efficacy of rejection prophylaxis with OKT3 in renal transplantation Transplantation 60 1995 1220 1224